PANKU-Breast02

An aspect marked incomplete is a question the public commentary did not let us answer. We show it rather than hide it.

Screened window

Feb 26, 2026 → Oct 20, 2026

Cited window

Feb 26, 2026 → Sep 3, 2026

Retrieved

Nov 1, 2026

Title

A Phase III Randomized Controlled Clinical Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer After Taxane Failure

Registry

NCT06382142

Study IDs

BL-B01D1-307

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Design

Phase 3 · Interventional, randomized, parallel

Status

Active, not recruiting

Enrollment

418 actual

Registered

2024-04-24

Start

2024-06-21 actual

Primary completion

2026-01-13 actual

Primary endpoint

Progression-free survival (PFS)

Interventions

5 registered

This report does not judge efficacy, estimate HCP prevalence or consensus or give treatment advice.

• –Discussion that does not name the trial may be missing from this edition.
• –Not yet captured in this edition: a view on standard-of-care adoption in pretreated metastatic triple-negative breast cancer.
• –Not yet captured in this edition: a view on treatment choice and tolerability in previously treated advanced triple-negative breast cancer.
• –Some passages in the sources used in this report were not fully assessed for clinician views, so a view there may be missing from this edition.
• –25 statements in the sources reviewed for this edition are about other patients or topics, or only mention the trial, and are not counted.
• –Further source limits: discussion that describes the trial without naming it may be incomplete; some discussion that describes the trial without naming it may be missing; sources about other trials are not included.
• –The sources reviewed for this edition are not a representative sample of HCP opinion. Multiple posts, clips and formats can repeat the same discussion rather than provide independent agreement.
• –Some potentially relevant passages were not fully assessed, and discussion that does not use familiar study names or identifiers may be absent. Additional qualifications or dissent may therefore be missing.
• –No protocol or original full trial-results publication was available. Numerical efficacy and safety findings are reported as what the contributors said, not as an independent analysis of the complete dataset.
• –Several passages cannot be assigned to a named speaker. Clinical roles are not established for every named contributor; source-stated credentials and trial involvement remain descriptions made by those sources.
• –Organizations, AI-generated forecasts, relayed presentation summaries and reposts must not be counted as additional independent HCP opinions.
• –Early topline and abstract-based comments reflect the information available in those particular communications. Differences in detail or publication date do not by themselves establish a change of mind.
• –Reported enrollment figures are inconsistent across posts and, in one post, with the separately listed arm sizes. These figures are not reconciled.
• –Regulatory information is incomplete. Expected FDA evidence requirements and descriptions of pending access are not formal regulatory decisions or proof of current availability in every location.

How reports are built and checked: Methods.

Last checked for new commentary Nov 1, 2026. A new or changed finding gets a new version number; added evidence alone is a smaller update. No corrections.

Paste this into ChatGPT, Claude, Microsoft Copilot or your own agent. It previews this report through the free Erudio MCP server, tells you whether it answers your question, and orders it if you ask. Some agents ask you to confirm pasted instructions before acting; that is expected.

Help me decide whether to buy the Erudio report "PANKU-Breast02" (NCT06382142), and buy it for me if I ask. Erudio reports cover what clinicians say in public about one clinical trial, with every verified statement linked to its source.

1. Use the free Erudio MCP server at https://mcp.erudio.com/free; it needs no sign-in. Nothing needs installing: if it is not connected in this app and you can make HTTP requests, call it directly with JSON-RPC POSTs to that URL (initialize, then tools/call), sending "Accept: application/json, text/event-stream". Call get_report_card with slug "panku-breast02-06382142". If you cannot make requests, read https://www.erudio.com/reports/panku-breast02-nct06382142.md instead.
2. In a few lines, tell me what the report covers: its findings, its verified statements and sources, its evidence window, what it leaves out, and the price of each product (offer). Then ask what I need it for, and say plainly whether this report answers it.
3. If I want it, ask for my work email and the product: the current edition, or 3, 6 or 12 months of weekly updates. Call create_order with report "NCT06382142", that product and email, then show me the quote and the checkout_url to pay by card. If you have a payment client for HTTP 402 payments and I agree, you can pay the pay_url instead. Nothing is charged until one is paid.
4. Once it is paid, call get_order with the status_url: it returns my license key. Then use the Erudio MCP server at https://mcp.erudio.com/mcp with the header "Authorization: Bearer <key>". Call read_report with report_id erudio-nct06382142 and sections ["all"], and summarize the findings for me with their sources. The full report is large (about 500 KB): save the response to a file and work from it rather than printing it. If you cannot, read sections ["narratives"] first, the executive summary and analysis.

When you tell me what clinicians said, give each view as theirs, with its source. Counts are the sources the report kept, not the share of clinicians who agree. Reports are not medical advice.
Keep the key private to my organization.

curl https://www.erudio.com/reports/panku-breast02-nct06382142.json
curl https://www.erudio.com/reports/panku-breast02-nct06382142.md

# MCP, no sign-in (https://mcp.erudio.com/free)
get_report_card({ "slug": "panku-breast02-06382142" })